Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.

作者: Ayman F. El-Kattan , Manthena V. S. Varma

DOI: 10.1124/DMD.117.080044

关键词: DrugOrganic cation transport proteinsTransporterPharmacologyDistribution (pharmacology)Organic anion-transporting polypeptideChemistryOrganic anion transporter 1PharmacogenomicsPharmacokinetics

摘要: Membrane transporters play an important role in the absorption, distribution, clearance, and elimination of drugs. Supported by pharmacokinetics data human, several including organic anion transporting polypeptide (OATP)1B1, OATP1B3, transporter (OAT)1, OAT3, cation (OCT)2, multidrug toxin extrusion (MATE) proteins, P-glycoprotein breast cancer resistance protein are suggested to be clinical relevance. An early understanding drug disposition clearance allows reliable prediction/evaluation changes due drug-drug interactions (DDIs) or genetic polymorphisms. We recently proposed extended classification system (ECCS) based on simple properties (i.e., ionization, permeability, molecular weight) predict predominant mechanism. According this framework, systemic class 1B 3B drugs is likely determined OATP-mediated hepatic uptake. Class 3A 4 drugs, certain predominantly cleared renal, wherein, OAT1, OCT2, MATE proteins could contribute their active renal secretion. Intestinal efflux uptake largely influence oral 3A, 3B, discuss paradigm applying ECCS framework mapping clinically relevant discovery development; thereby implementing right strategy allow optimization exposure evaluation risk DDIs pharmacogenomics.

参考文章(104)
Brian Davies, Tim Morris, Physiological Parameters in Laboratory Animals and Humans Pharmaceutical Research. ,vol. 10, pp. 1093- 1095 ,(1993) , 10.1023/A:1018943613122
Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison, A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability Pharmaceutical Research. ,vol. 12, pp. 413- 420 ,(1995) , 10.1023/A:1016212804288
Hans Lennernaäs, Human intestinal permeability. Journal of Pharmaceutical Sciences. ,vol. 87, pp. 403- 410 ,(1998) , 10.1021/JS970332A
Gina L. Sirianni, K. Sandy Pang, Organ Clearance Concepts: New Perspectives on Old Principles Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 25, pp. 449- 470 ,(1997) , 10.1023/A:1025792925854
J Snoeys, M Beumont, M Monshouwer, S Ouwerkerk-Mahadevan, Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach. Clinical Pharmacology & Therapeutics. ,vol. 99, pp. 224- 234 ,(2016) , 10.1002/CPT.206
SLCO1B1 variants and statin-induced myopathy--a genomewide study The New England Journal of Medicine. ,vol. 359, pp. 789- 799 ,(2008) , 10.1056/NEJMOA0801936
Wooin Lee, Richard B. Kim, Transporters and Renal Drug Elimination Annual Review of Pharmacology and Toxicology. ,vol. 44, pp. 137- 166 ,(2004) , 10.1146/ANNUREV.PHARMTOX.44.101802.121856
Yoshihisa Shitara, Kazuya Maeda, Kazuaki Ikejiri, Kenta Yoshida, Toshiharu Horie, Yuichi Sugiyama, Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption Biopharmaceutics & Drug Disposition. ,vol. 34, pp. 45- 78 ,(2013) , 10.1002/BDD.1823